IBD: measuring what counts-safety of IBD medications in pregnancy
- PMID: 21304477
- DOI: 10.1038/nrgastro.2011.18
IBD: measuring what counts-safety of IBD medications in pregnancy
Abstract
Uncertainty about the risks of medications for IBD during pregnancy is a challenge for clinicians and patients. a recent prospective cohort study suggests that women under medical care for their disease have few adverse events.
Similar articles
-
Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study.Clin Gastroenterol Hepatol. 2017 Aug;15(8):1232-1241.e1. doi: 10.1016/j.cgh.2017.02.041. Epub 2017 Mar 22. Clin Gastroenterol Hepatol. 2017. PMID: 28342949
-
Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease.J Crohns Colitis. 2015 Mar;9(3):223-30. doi: 10.1093/ecco-jcc/jjv006. Epub 2015 Jan 9. J Crohns Colitis. 2015. PMID: 25576754
-
Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel Disease.J Crohns Colitis. 2016 Aug;10(8):892-7. doi: 10.1093/ecco-jcc/jjw052. Epub 2016 Feb 19. J Crohns Colitis. 2016. PMID: 26896087
-
[Inflammatory bowel disease and pregnancy].Eksp Klin Gastroenterol. 2012;(3):80-6. Eksp Klin Gastroenterol. 2012. PMID: 22830229 Review. Russian.
-
The role of thiopurine metabolites in inflammatory bowel disease and rheumatological disorders.Int J Rheum Dis. 2014 Feb;17(2):132-41. doi: 10.1111/1756-185X.12204. Int J Rheum Dis. 2014. PMID: 24618304 Review.
Cited by
-
Inflammatory bowel disease, women, and pregnancy.Gastroenterol Hepatol (N Y). 2013 Nov;9(11):741-3. Gastroenterol Hepatol (N Y). 2013. PMID: 24764792 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical